Aptitude's next-generation Metrix COVID/Flu Test is also currently under FDA review for 510 (k) clearance, continuing the ...
Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product ...
Sling Therapeutics is advancing the first late-stage oral drug for thyroid eye disease that, if approved, could compete ...
Bernstein Best of Biotech Symposium 2.0 Thursday, September 24, 2026: BofA Securities Healthcare Trailblazers Private Company ...
(Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, ...
James P. Kelly, MD, Chief Medical Officer of Oragenics, is scheduled to present in the Successful Case Studies session at the ...
BioSpace takes stock of the psychedelic therapeutics space, which is once again on the cusp of its first FDA approval.
The full technical case study, "Predicting Neurotoxicity Risk via AChE Inhibition Modeling from Chemical Structure," is ...
The $925 million (CAD) expansion is adding end-to-end vaccine manufacturing capacity on Canadian soil Built in partnership ...
After reviewing Bausch & Lomb’s response to its observations, the FDA questioned whether the company is committed to ...
The FDA held a public forum on Monday to discuss the future of psychedelic therapeutics, followed by a meeting on Wednesday ...
A growing number of biotechs are entering the market with newly launched medicines, a pattern indicative of “improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results